• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症的心脏磁共振成像:高分辨率下的心脏受累情况

Cardiac magnetic resonance imaging in systemic sclerosis: Heart involvement in high-resolution.

作者信息

Fairley Jessica L, O'Rourke Rachael, Puranik Rajesh, Nikpour Mandana

机构信息

The University of Melbourne, Melbourne, Victoria, Australia.

St. Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.

出版信息

Rheumatol Immunol Res. 2024 Jul 15;5(2):83-92. doi: 10.1515/rir-2024-0011. eCollection 2024 Jun.

DOI:10.1515/rir-2024-0011
PMID:39015845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11248552/
Abstract

Cardiac magnetic resonance imaging (CMR) is the gold-standard non-invasive method of assessing cardiac structure and function, including tissue characterisation. In systemic sclerosis (SSc), heart involvement (SHI) is a leading cause of mortality yet remains poorly understood. SHI is underestimated by conventional echocardiography, and CMR provides an important opportunity to better identify and quantify subtle myocardial changes including oedema and fibrosis. This review summarises current CMR techniques, the role of CMR in SSc and SHI, and the opportunities to further our understanding of its pathogenesis and management.

摘要

心脏磁共振成像(CMR)是评估心脏结构和功能(包括组织特征)的金标准非侵入性方法。在系统性硬化症(SSc)中,心脏受累(SHI)是主要的死亡原因,但仍未得到充分了解。传统超声心动图会低估SHI,而CMR提供了一个重要机会,能更好地识别和量化包括水肿和纤维化在内的细微心肌变化。本综述总结了当前的CMR技术、CMR在SSc和SHI中的作用,以及进一步了解其发病机制和治疗方法的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6f/11248552/69643989a2a9/j_rir-2024-0011_fig_004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6f/11248552/574a49466da7/j_rir-2024-0011_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6f/11248552/09dff07b9317/j_rir-2024-0011_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6f/11248552/d285298fcf42/j_rir-2024-0011_fig_003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6f/11248552/69643989a2a9/j_rir-2024-0011_fig_004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6f/11248552/574a49466da7/j_rir-2024-0011_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6f/11248552/09dff07b9317/j_rir-2024-0011_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6f/11248552/d285298fcf42/j_rir-2024-0011_fig_003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6f/11248552/69643989a2a9/j_rir-2024-0011_fig_004.jpg

相似文献

1
Cardiac magnetic resonance imaging in systemic sclerosis: Heart involvement in high-resolution.系统性硬化症的心脏磁共振成像:高分辨率下的心脏受累情况
Rheumatol Immunol Res. 2024 Jul 15;5(2):83-92. doi: 10.1515/rir-2024-0011. eCollection 2024 Jun.
2
Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging.心脏受累于系统性硬化症:磁共振成像的作用
Clin Rev Allergy Immunol. 2023 Jun;64(3):343-357. doi: 10.1007/s12016-022-08923-3. Epub 2022 Jan 24.
3
T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.心脏磁共振 T1 mapping 成像技术常可检测出系统性硬化症患者亚临床弥漫性心肌纤维化。
Semin Arthritis Rheum. 2020 Feb;50(1):128-134. doi: 10.1016/j.semarthrit.2019.06.013. Epub 2019 Jun 19.
4
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI).使用延迟增强心脏磁共振(CE-MRI)对系统性硬化症(SSc)的亚临床心脏受累进行早期评估。
Eur J Radiol. 2013 Jun;82(6):e268-73. doi: 10.1016/j.ejrad.2013.02.014. Epub 2013 Mar 16.
5
Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.系统性硬皮病相关肺动脉高压患者的外周微血管功能与心血管磁共振上的心脏受累有关。
Eur Heart J Cardiovasc Imaging. 2024 Apr 30;25(5):708-717. doi: 10.1093/ehjci/jeae001.
6
Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls".系统性硬皮病的心血管磁共振:“要点与陷阱”。
Semin Arthritis Rheum. 2017 Aug;47(1):79-85. doi: 10.1016/j.semarthrit.2017.03.020. Epub 2017 Mar 31.
7
Current advances in cardiac magnetic resonance imaging in systemic sclerosis.系统性硬化症的心脏磁共振成像的最新进展。
Eur Rev Med Pharmacol Sci. 2021 May;25(10):3718-3736. doi: 10.26355/eurrev_202105_25940.
8
The presence of abnormal septal motion on echocardiography is a predictor of abnormal cardiac magnetic resonance in systemic sclerosis.超声心动图上出现异常室间隔运动是系统性硬化症患者心脏磁共振异常的预测指标。
Rheumatology (Oxford). 2024 Feb 1;63(2):482-489. doi: 10.1093/rheumatology/kead235.
9
Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management.用于系统性硬化症监测与管理的心血管成像
Front Cardiovasc Med. 2022 Mar 31;9:846213. doi: 10.3389/fcvm.2022.846213. eCollection 2022.
10
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis.数字溃疡和室性心律失常作为预测系统性硬化症中替代性心肌纤维化的危险信号。
J Clin Med. 2023 Dec 23;13(1):89. doi: 10.3390/jcm13010089.

引用本文的文献

1
Assessment of right ventricular involvement in patients with anti-MDA5 Ab+ DM: a prospectively observational study with cardiac magnetic resonance imaging.抗MDA5抗体阳性皮肌炎患者右心室受累情况的评估:一项采用心脏磁共振成像的前瞻性观察研究。
Front Cardiovasc Med. 2025 May 2;12:1558800. doi: 10.3389/fcvm.2025.1558800. eCollection 2025.
2
The prognostic value of HFA-PEFF score in connective tissue disease-associated PAH: evidence from a cohort study.HFA-PEFF评分在结缔组织病相关肺动脉高压中的预后价值:一项队列研究的证据
BMC Cardiovasc Disord. 2025 Apr 5;25(1):258. doi: 10.1186/s12872-025-04691-y.
3
[COVID-19 vaccines efficacy and infection features in patients with systemic sclerosis: A single-center cohort study].

本文引用的文献

1
Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis.系统性硬化症中显性和亚临床左心室收缩功能障碍的预后和功能重要性。
Semin Arthritis Rheum. 2024 Jun;66:152443. doi: 10.1016/j.semarthrit.2024.152443. Epub 2024 Apr 6.
2
Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis-Associated Interstitial Lung Disease.左心室舒张功能障碍对系统性硬化症相关间质性肺病患者生存和呼吸困难的影响。
J Rheumatol. 2024 May 1;51(5):495-504. doi: 10.3899/jrheum.2023-0801.
3
Cardiac magnetic resonance imaging of pericardial diseases: a comprehensive guide.
[新冠病毒疫苗对系统性硬化症患者的疗效及感染特征:一项单中心队列研究]
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Dec 18;56(6):1041-1046. doi: 10.19723/j.issn.1671-167X.2024.06.015.
心脏磁共振成像在心脏疾病诊断中的应用:全面指南。
Eur Heart J Cardiovasc Imaging. 2023 Jul 24;24(8):983-998. doi: 10.1093/ehjci/jead092.
4
Subclinical Systemic Sclerosis Primary Heart Involvement by Cardiovascular Magnetic Resonance Shows No Significant Interval Change.亚临床系统性硬化症:心血管磁共振显示原发性心脏受累无明显间隔期变化
ACR Open Rheumatol. 2023 Feb;5(2):71-80. doi: 10.1002/acr2.11515. Epub 2023 Jan 5.
5
Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study.尼达尼布对系统性硬皮病患者心肌病的有益作用:一项初步研究。
Rheumatology (Oxford). 2023 Jul 5;62(7):2550-2555. doi: 10.1093/rheumatology/keac674.
6
Cardiac inflammation and fibrosis patterns in systemic sclerosis, evaluated by magnetic resonance imaging: An update.磁共振成像评估系统性硬化症的心肌炎症和纤维化模式:更新。
Semin Arthritis Rheum. 2023 Feb;58:152126. doi: 10.1016/j.semarthrit.2022.152126. Epub 2022 Nov 18.
7
Diffuse myocardial fibrosis precedes subclinical functional myocardial impairment and provides prognostic information in systemic sclerosis.弥漫性心肌纤维化先于亚临床功能性心肌损害出现,并为系统性硬化症提供预后信息。
Eur Heart J Cardiovasc Imaging. 2023 Feb 17;24(3):373-382. doi: 10.1093/ehjci/jeac094.
8
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation.系统性硬皮病心肌炎的心脏磁共振:T2 映射检测心肌炎症的价值。
Rheumatology (Oxford). 2022 Nov 2;61(11):4409-4419. doi: 10.1093/rheumatology/keac098.
9
Myocardial fibrosis and arrhythmic burden in systemic sclerosis.系统性硬化症中的心肌纤维化与心律失常负担
Rheumatology (Oxford). 2022 Nov 2;61(11):4497-4502. doi: 10.1093/rheumatology/keac065.
10
Artificial Intelligence in Cardiac MRI: Is Clinical Adoption Forthcoming?心脏磁共振成像中的人工智能:临床应用即将到来吗?
Front Cardiovasc Med. 2022 Jan 10;8:818765. doi: 10.3389/fcvm.2021.818765. eCollection 2021.